4 - PRECISION OPTICS CORPORATION, INC. (0000867840) (Issuer)

4 - PRECISION OPTICS CORPORATION, INC. (0000867840) (Issuer)

4 - PRECISION OPTICS CORPORATION, INC. (0000867840) (Issuer)

SC 13G/A - PRECISION OPTICS CORPORATION, INC. (0000867840) (Subject)

SC 13G - PRECISION OPTICS CORPORATION, INC. (0000867840) (Subject)

GARDNER, Mass., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ:POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced an initial $340,000 production order from a large, global medical device company to provide initial stocking quantities of a new single-use ophthalmic endoscope. Production is scheduled to begin in January 2025 and proceed over the following five months, to provide starting inventory levels to support product launch currently expected to occur around June 2025. The Company expects follow-on orders to support first year requirements after lau

GARDNER, Mass., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ:POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, announced operating results on an unaudited basis for its first quarter fiscal year 2025 for the period ended September 30, 2024. Q1 2025 Financial Highlights (3 Months Ended September 30, 2024): Revenue was $4.2 million compared to $4.3 million in the same quarter of the previous fiscal year and in line with the expectations provided in September 2024.Engineering revenue was $1.9 million compared to $1.9 million in the same quarter of the previous fiscal year.Production re

GARDNER, Mass., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ:POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced that it has scheduled a conference call to discuss the Company's first quarter fiscal year 2025 financial results on Thursday, November 14, 2024, at 5:00pm ET. The Company intends to release its financial results and to file its 10-Q after the close of the market on Thursday, November 14, 2024, followed by the conference call. Conference Call Details Date and Time: Thursday, November 14, 2024, at 5:00pm ET Call-in Information: Interested pa

GARDNER, Mass., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ:POCI) ("POC"), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced that its customer, a surgical robotics company focused on transformative solutions in urology, recently announced FDA 510(k) clearance of its next-generation AI-powered platform for treatment of Benign Prostate Hyperplasia. Precision Optics designed and currently manufactures the single-use endoscope imaging assembly used within the new system. "We are excited by the news and congratulate our customer's entire team on receiving FDA 510(k) clearance for their re

GARDNER, Mass., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ:POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, announced today it will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Fall 2024 Investor Conference, taking place virtually today, Tuesday, October 1, 2024. Company Webcast Precision Optics' webcast presentation will begin at 1:15 pm ET on Tuesday, October 1. Access will be available via the conference home page at https://lythampartners.com/fall2024/ or directly at https://app.webinar.net/qvBOJq

GARDNER, Mass., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ:POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, announced operating results on an unaudited basis for its fourth quarter and fiscal year ended June 30, 2024. FY 2024 Financial Highlights (Year Ended June 30, 2024): Revenue was $19.1 million compared to $21.0 million in the previous fiscal year. Revenue of $19.1 million, exceeded the high end of the expected range announced on August 14, 2024 of $18.9 million.Production revenue was $10.8 million, a decrease of 25% compared to the previous fiscal year.Engineering revenue

GARDNER, Mass., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ:POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced that it has scheduled a conference call to discuss the Company's fourth quarter and fiscal year 2024 financial results on Monday, September 30, 2024, at 5:00pm ET. The Company intends to release its financial results and to file its 10-K after the close of the market on Monday, September 30, 2024, followed by the conference call. Conference Call Details Date and Time: Monday, September 30, 2024, at 5:00pm ET Call-in Informa

GARDNER, Mass., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ:POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced that it has entered into securities purchase agreements with institutional and accredited investors in addition to certain directors and officers of the Company for the purchase and sale of 265,868 shares of the Company's common stock, par value $0.01 per share, pursuant to a registered direct offering at a purchase price of $5.25 per share for the institutional and accredited investors and $5.79 per share for the directors and officers, resulting in gro

GARDNER, Mass., July 08, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ:POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced the appointment of Clay Schwabe, as the Company's Vice President of Sales and Marketing. Mr. Schwabe has over fifteen years of experience in medical device market access, sales, sales management, global product marketing, and commercialization. He is an emerging technologies specialist with experience in early-stage commercialization of minimally invasive surgical products and procedures. Most recently, he served as VP Business Development, Commercial Strategy, CRO, an

GARDNER, Mass., May 23, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ:POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced that Dr. Joe Forkey, Chief Executive Officer, will participate in a webcasted presentation and host one-on-one meetings with investors at the Lytham Partners Spring 2024 Investor Conference, taking place virtually on Thursday, May 30, 2024. Company WebcastThe webcasted presentation will take place at 1:15pm ET on Thursday, May 30, 2024. The webcast can be accessed by visiting the conference home page at https://lythampartners.com/spring2024/ or directly at https://wsw.c

GARDNER, Mass., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ:POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced that it has scheduled a conference call to discuss the Company's first quarter fiscal year 2025 financial results on Thursday, November 14, 2024, at 5:00pm ET. The Company intends to release its financial results and to file its 10-Q after the close of the market on Thursday, November 14, 2024, followed by the conference call. Conference Call Details Date and Time: Thursday, November 14, 2024, at 5:00pm ET Call-in Information: Interested pa

GARDNER, Mass., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ:POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced that it has scheduled a conference call to discuss the Company's fourth quarter and fiscal year 2024 financial results on Monday, September 30, 2024, at 5:00pm ET. The Company intends to release its financial results and to file its 10-K after the close of the market on Monday, September 30, 2024, followed by the conference call. Conference Call Details Date and Time: Monday, September 30, 2024, at 5:00pm ET Call-in Informa

GARDNER, Mass., May 15, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ:POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, announced operating results on an unaudited basis for its third quarter fiscal year 2024 for the period ended March 31, 2024. Q3 2024 Financial Highlights (3 Months Ended March 31, 2024): Revenue increased 4% to $5.2 million, compared to $5.0 million in the same quarter of the previous fiscal year, and up 9% compared to the most recent sequential quarter.Engineering revenue increased 62% to $2.3 million compared to $1.4 million in the same quarter of the previous fiscal year, represen

GARDNER, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ:POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced that it has scheduled a conference call to discuss third quarter of fiscal year 2024 financial results on Wednesday, May 15, 2024, at 5:00pm ET. The Company intends to release its financial results and to file its 10-Q after the close of the market on Wednesday, May 15, 2024, followed by the conference call. Conference Call Details Date and Time: Wednesday, May 15, 2024, at 5:00pm ET Call-in Information: Interested parties can access the conference ca

Conference Call Scheduled for today, February 14, 2024, at 5:00pm ET. GARDNER, Mass., Feb. 14, 2024 /PRNewswire/ -- Precision Optics Corporation, Inc. (NASDAQ:POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, announced operating results on an unaudited basis for its second quarter fiscal year 2024 for the period ended December 31, 2023. Q2 2024 Financial Highlights (3 Months Ended December 31, 2023): Revenue decreased 18% to $4.8 million, compared to $5.9 million in the same quarter of the previous fiscal year, b

GARDNER, Mass., Feb. 8, 2024 /PRNewswire/ -- Precision Optics Corporation, Inc. (NASDAQ:POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced that it has scheduled a conference call to discuss second quarter of fiscal year 2024 financial results on Wednesday, February 14, 2024, at 5:00pm ET. The Company intends to release its financial results and to file its 10-Q after the close of the market on Wednesday, February 14, 2024, followed by the conference call. Conference Call Details Dat

Conference Call Scheduled for today, November 14, 2023, at 5:00pm ET. GARDNER, Mass., Nov. 14, 2023 /PRNewswire/ -- Precision Optics Corporation, Inc. (NASDAQ:POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, announced operating results on an unaudited basis for its first quarter fiscal year 2024 for the period ended September 30, 2023. Q1 2024 Financial Highlights (3 Months Ended September 30, 2023): Revenue decreased 15% to $4.3 million, compared to $5.1 million in the same quarter of the previous fiscal year.P

Conference Call Scheduled for today, September 28, 2023, at 5:00pm ET GARDNER, Mass., Sept. 28, 2023 /PRNewswire/ -- Precision Optics Corporation, Inc. (NASDAQ:POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, announced operating results on an unaudited basis for its fourth quarter and fiscal year ended June 30, 2023. FY 2023 Financial Highlights (Year Ended June 30, 2023): Revenue increased 34% to $21.0 million, a new record, compared to $15.7 million in the previous fiscal year.Production revenue reached a new

GARDNER, Mass., Sept. 25, 2023 /PRNewswire/ -- Precision Optics Corporation, Inc. (NASDAQ:POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced that it has scheduled a conference call to discuss fourth quarter and fiscal year 2023 financial results on Thursday, September 28, 2023, at 5:00pm ET. The Company intends to release its financial results and to file its 10-K after the close of the market on Thursday, September 28, 2023, followed by the conference call. Conference Call Details

Conference Call Scheduled for today, May 15, 2023 at 5:00pm ET GARDNER, Mass., May 15, 2023 /PRNewswire/ -- Precision Optics Corporation, Inc. (NASDAQ:POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, announced operating results on an unaudited basis for its third quarter fiscal year 2023. Third quarter fiscal 2023 financial highlights: Revenue for the quarter ended March 31, 2023, increased 9% to $5.05 million, compared to $4.65 million in the same quarter of the previous fiscal year.Production revenue reached a

– SEC Filing

Precision Optics Corporation, Inc. (NASDAQ:POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced a $9 million production order from a leading surgical company to supply single-use endoscope assemblies used in their cystoscopy surgery system. The assembly draws on POC's unique micro-optics and digital imaging technologies. This is the largest order POC has ever received and illustrates the opportunities that single-use applications provide to the Company. Production deliveries are scheduled to begin July 2024 and proceed over several quarters. The Company presently estimates approximately $2.2 million in deliveries d

Precision Optics Corporation, Inc. (NASDAQ:POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced it has received a $720,000 follow on production order from a top tier defense/aerospace company addressing a commercial application that leverages the Company's proprietary manufacturing technology developed for high precision micro-optics systems. The Company received an initial $680,000 production order as of September 2023, and $517,000 in follow on production orders in November and December 2023. With today's announcement, total production orders for this leading-edge application now total more than $1.9 million. All

Precision Optics Corp (NASDAQ:POCI) reported quarterly losses of $(0.13) per share. This is a 218.18 percent decrease over earnings of $0.11 per share from the same period last year. The company reported $4.82 million in sales this quarter. This is a 18.06 percent decrease over sales of $5.89 million the same period last year.

Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is projected to report quarterly earnings at $1.65 per share on revenue of $24.62 billion. • CAE (NYSE:CAE) is estimated to report quarterly earnings at $0.18 per share on revenue of $819.57 million. • CNH Industrial (NYSE:CNHI) is estimated to report quarterly earnings at $0.42 per share on revenue of $6.66 billion. • Great Lakes Dredge & Dock (NASDAQ:GLDD) is estimated to report quarterly earnings at $0.10 per share on revenue of $183.47 million. • Louisiana-Pacific (NYSE:LPX) is likely to report quarterly earnings at $0.55 per share on revenue of $619.97 million. • Martin Marietta Materials (NYSE:MLM) is projected to repor

Precision Optics Corp (NASDAQ:POCI) reported quarterly losses of $(0.08) per share. This is a 166.67 percent decrease over losses of $(0.03) per share from the same period last year. The company reported $4.32 million in sales this quarter. This is a 15.02 percent decrease over sales of $5.09 million the same period last year.